您的购物车当前为空
别名 泽罗妥单抗, UC-961, Cirmtuzumab, 1643432-38-5
Zilovertamab (UC-961) 是一种人源化抗 ROR1 单克隆抗体,可切断 Wnt5a 诱导的 ROR1 信号通路,在卵巢癌和子宫内膜癌细胞中显示出抗增殖活性。可用于研究淋巴癌。

为众多的药物研发团队赋能,
让新药发现更简单!
Zilovertamab (UC-961) 是一种人源化抗 ROR1 单克隆抗体,可切断 Wnt5a 诱导的 ROR1 信号通路,在卵巢癌和子宫内膜癌细胞中显示出抗增殖活性。可用于研究淋巴癌。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,880 | In Stock | |
| 5 mg | ¥ 7,880 | In Stock | |
| 10 mg | ¥ 10,800 | In Stock | |
| 25 mg | ¥ 15,900 | In Stock | |
| 50 mg | ¥ 21,700 | In Stock | |
| 100 mg | ¥ 29,300 | In Stock |
| 产品描述 | Zilovertamab (UC-961) is a humanized anti-ROR1 monoclonal antibody that cuts off the WNT5A-induced ROR1 signaling pathway and shows anti-proliferative activity in ovarian and endometrial cancer cells. It can be used to study lymphatic cancer. |
| 体外活性 | Zilovertamab(25和50 µg/mL;72小时)能够抑制高级浆液性卵巢癌(HGSOC)细胞的增殖[1]。Zilovertamab(50 µg/mL;72小时)在转录水平上下调CaOV3中ROR1的表达水平[1]。 |
| 别名 | 泽罗妥单抗, UC-961, Cirmtuzumab, 1643432-38-5 |
| CAS No. | 2485779-13-1 |
| 颜色 | Transparent |
| 物理性状 | Liquid |
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容